LY-900009

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLY-900009
Drug Alias NameLY-900009
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-secretase inhibitors
TargetsGamma-secretase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A